ArticleBMC public health2026
Prevalence, subtypes, and comorbidity of DSM-5 insomnia disorder among adults in Beijing, China: a large-scale cross-sectional study.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Effectiveness of Wearable Digital Therapeutics in Improving Sleep Outcomes Among Individuals With Insomnia: Systematic Review and Meta-Analysis of Randomized Controlled Trials.Journal of medical Internet research · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundDespite the crucial distinction between insomnia symptoms and a diagnosed disorder, population-level studies based on contemporary criteria and clinical interviews are scarce. This study therefore examined the insomnia spectrum by assessing the prevalence, identifying subtypes, and exploring associations with sociodemographic factors and comorbid mental disorders for both conditions.
methodsThis large-scale, community-based cross-sectional study was conducted in Beijing from October to December 2021. A sample of 10,778 adults was recruited via multistage stratified random sampling. Trained psychiatrists conducted standardized diagnostic interviews based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) to collect data on insomnia disorder and mental disorders. Descriptive analysis and weighted Rao-Scott chi-square tests, were performed using the Statistical Analysis System (SAS, version 9.4).
resultsThe weighted prevalence rates were 17.7% for subjective sleep problems, 10.7% for clinically assessed insomnia symptoms, and 3.0% for DSM-5-diagnosed insomnia disorder. Among insomnia subtypes, initial insomnia was most prevalent, both as a symptom (8.1%) and a disorder (2.6%). Furthermore, insomnia disorder prevalence varied by sociodemographics, being higher in females, older adults (≥ 60 years), and those with lower education. Among individuals with insomnia disorder, 31.3% had comorbid other mental disorders, particularly alcohol-related disorders (13.4%). Conversely, insomnia disorder was observed in 14.4% of individuals with other mental disorders, with the highest prevalence in depressive (21.4%) and anxiety disorders (19.2%).
conclusionsThe marked disparity between prevalent insomnia symptoms and formal diagnoses, compounded by significant psychiatric comorbidity, mandates a public health shift toward population-level screening and early intervention. This imperative includes adopting standardized diagnostics and implementing integrated, transdiagnostic treatment models as a pivotal preventive strategy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.